In a pilot study, Ueda et al. reported that metabolic responders on FDG PET/CT after 4 weeks of neoadjuvant letrozole was associated with a significant decrease in tumor Ki67 expression level, whereas morphological response was not [43]. The gene discussed is MKI67; the disease is neoplasm.